Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BioMEL - a Translational Study About Aetiology, Diagnosis, Prognosis, Treatment, Biology and Biomarkers in Clinically Atypical Nevi and Melanoma.

NCT05446155 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT05446155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05446155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BioMEL - a Translational Study About Aetiology, Diagnosis, Prognosis, Treatment, Biology and Biomarkers in Clinically Atypical Nevi and Melanoma.
Lead sponsor
Region Skane
Phase
Observational
Overall status
Recruiting
Start date
November 4, 2013
Completion date
December 31, 2028
Enrollment
2,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

dysplastic nevi, image, melanoma, melanoma in situ, mole (dermatology), mutation